Fully human antibody Fab fragments with human interferon-gamma neutralizing activity
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Aug 1, 2006
Grant Date -
May 29, 2003
app pub date -
Oct 5, 2001
filing date -
Oct 5, 2001
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Selective binding agents of interferon-gamma (IFN.gamma.) are provided by the invention. More particularly, the invention provides for antibodies and antigen binding domains which selectively bind to IFN.gamma. and may be used to prevent or treat conditions relating to autoimmune and inflammatory diseases such as rheumatoid arthritis, systemic lupus erythematosus and multiple sclerosis. Nucleic acid molecules encoding said antibodies and antigen binding domains, and expression vectors and host cells for the production of same are also provided.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully